BioHarvest Sciences Stock (NASDAQ:BHST)

Revenue Financials Chart Transcripts

Previous Close

$7.28

52W Range

$4.66 - $7.86

50D Avg

$6.32

200D Avg

$5.85

Market Cap

$132.77M

Avg Vol (3M)

$24.48K

Beta

1.29

Div Yield

-

BHST Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Industry

Agricultural - Commodities/Milling

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

CA

Employees

87

IPO Date

-

Website

BHST Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24
Products	$24.91M
Total	$25.19M

Fiscal year ends in Dec 24 | Currency in USD

BHST Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$25.19M	$12.67M	$5.50M
Operating Income	$-6.99M	$-9.97M	$-10.61M
Net Income	$-12.91M	$-12.56M	$-11.24M
EBITDA	$-6.92M	$-9.76M	$-9.13M
Basic EPS	$-0.80	$-0.93	$-0.70
Diluted EPS	$-0.80	$-0.93	$-0.70

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 31, 25 | 4:30 PM

Q3 24Nov 25, 24 | 4:30 PM